Cambridge, MA · Founded 2023 · Privately Held (backing)
Developer of a neural interface technology designed to enhance the integration of bioelectronics with the human body. NeuroBionics is based in Cambridge, MA and was founded in 2023. It was valued at $33.3 million at its seed round in Dec 2025, the last priced event on record. It has raised $9.3 million across 1 recorded round; the latest was a $4.2 million seed round in Nov 2025.
PMV mark · valuation
$33.3M
Oct 2026
Priced at
its seed round
Dec 2025
Total raised
$9.3M
Last round
Seed Round
Nov 2025
Cap table — not yet on record
NeuroBionics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of NeuroBionics with a free account
·The complete investor list: 19 names
·Watch NeuroBionics: the Monday email on marks, rounds and moves